8-Cl-Ado

N/A

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug Name8-Cl-Ado
Drug Alias Name8-Cl-AdoNSC-354258
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsTelomerase reverse transcriptaseProtein kinase AMP-activated non-catalytic subunit beta 1AMP-activated protein kinases
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstitutePeking University Health Science Center
China Registration ClassN/A

Develop Information

Active CompaniesPeking University Health Science CenterNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A